Synopsysの空売り状況は、投資家がSynopsysの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Synopsys (NASDAQ:SNPS) 株価情報, 空売り情報

Synopsys

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Synopsys Inc

<p>Analysts' ratings for Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) over the last quarter vary from bullish to bearish, as provided by 6 analysts.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $644.17, a high estimate of $675.00, and a low estimate of $570.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 2.91%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732284009_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Synopsys. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gary Mobley</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$570.00</td>
<td>-</td>
</tr>
<tr>
<td>Gary Mobley</td>
<td>Loop Capital</td>
<td>Announces</td>
<td>Buy</td>
<td>$675.00</td>
<td>-</td>
</tr>
<tr>
<td>Clarke Jeffries</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$670.00</td>
<td>$687.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$640.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Outperform</td>
<td>$650.00</td>
<td>-</td>
</tr>
<tr>
<td>Nay Soe Naing</td>
<td>Berenberg</td>
<td>Announces</td>
<td>Buy</td>
<td>$660.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Synopsys. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Synopsys compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Synopsys's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Synopsys's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SNPS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Synopsys analyst ratings.</strong></a></p>
<h2>Delving into Synopsys's Background</h2>
<p>Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.</p>
<h3>Financial Insights: Synopsys</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Synopsys showcased positive performance, achieving a revenue growth rate of <strong>12.65%</strong> as of 31 July, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Synopsys's net margin is impressive, surpassing industry averages. With a net margin of <strong>26.74%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>5.49%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Synopsys's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>3.6%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Synopsys's debt-to-equity ratio is below the industry average at <strong>0.09</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

SNPS

The Analyst Landscape: 6 Takes On Synopsys

<p>Wells Fargo  analyst Gary Mobley   initiates coverage on Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Equal-Weight rating and announces Price Target of $570.</p>


News

Price Target

Initiation

Wells Fargo Initiates Coverage On Synopsys with Equal-Weight Rating, Announces Price Target of $570

<p>Deep-pocketed investors have adopted a bearish approach towards Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SNPS usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Synopsys. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 25% leaning bullish and 37% bearish. Among these notable options, 3 are puts, totaling $88,885, and 5 are calls, amounting to $268,163.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $520.0 to $670.0 for Synopsys during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of Synopsys stands at 140.67, with a total volume reaching 322.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Synopsys, situated within the strike price corridor from $520.0 to $670.0, throughout the last 30 days.</p>
<h3>Synopsys Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731688340_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$54.7</td>
<td>$54.5</td>
<td>$54.5</td>
<td>$600.00</td>
<td>$76.3K</td>
<td align="right">13</td>
<td align="right">18</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$41.8</td>
<td>$36.7</td>
<td>$38.0</td>
<td>$520.00</td>
<td>$61.7K</td>
<td align="right">43</td>
<td align="right">0</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$620.00</td>
<td>$46.2K</td>
<td align="right">367</td>
<td align="right">154</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$29.3</td>
<td>$28.4</td>
<td>$28.0</td>
<td>$540.00</td>
<td>$45.7K</td>
<td align="right">105</td>
<td align="right">5</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$54.5</td>
<td>$54.5</td>
<td>$54.5</td>
<td>$600.00</td>
<td>$38.1K</td>
<td align="right">13</td>
<td align="right">33</td>
</tr>
</tbody>
</table>
</p>
<h3>About Synopsys</h3>
<p>Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.</p>
<p>Having examined the options trading patterns of Synopsys, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Synopsys's Current Market Status</h3>
<ul>
<li>With a trading volume of 217,362, the price of SNPS is down by -3.59%, reaching $528.62.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 19 days from now.</li>
</ul>
<h3>Expert Opinions on Synopsys</h3>
<p>A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $658.75.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Loop Capital downgraded its action to Buy with a price target of $675.<br />
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Synopsys with a target price of $670.<br />
&#x2A; In a cautious move, an analyst from Mizuho downgraded its rating to Outperform, setting a price target of $650.<br />
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $640. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Synopsys options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

Markets

Synopsys Unusual Options Activity

<p>Loop Capital  analyst Gary Mobley   initiates coverage on Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy rating and announces Price Target of $675.</p>


Loop Capital Initiates Coverage On Synopsys with Buy Rating, Announces Price Target of $675

WIIM

ACIW

ADBE

ADEA

ADSK

AEYE

AGYS

AISP

AIXI

ALKT

ANSS

APPF

APPN

ARBK

ASAN

BILL

BLKB

BRZE

BTCM

BTCS

BTCT

CCSI

CIFR

CRWD

CVLT

CWAN

CYBR

DATS

DJCO

DOCU

DOMO

EGAN

EVCM

FICO

FTNT

GRYP

GTLB

HTCR

HUBS

IDAI

IDCC

INTA

INTU

IREN

KVYO

LMFA

MANH

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MNDY

MSTR

NCNO

ORCL

PANW

PCOR

PLTR

SDIG

SLNH

SOUN

SPNS

SPSC

SSTI

TENB

VRNS

WDAY

XTKG

ZETA

Shares of software companies are trading higher in sympathy with overall market strength after Donald Trump was elected president of the United States.

<p>Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) has outperformed the market over the past 5 years by 17.8% on an annualized basis producing an average annual return of 31.47%. Currently, Synopsys has a market capitalization of $81.29 billion. </p>
<p><strong>Buying $100 In SNPS:</strong> If an investor had bought $100 of SNPS stock 5 years ago, it would be worth <strong>$392.41</strong> today based on a price of $529.21 for SNPS at the time of writing.</p>
<h3>Synopsys's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1730300413_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

Here's How Much You Would Have Made Owning Synopsys Stock In The Last 5 Years

Synopsys shares are trading higher in possible sympathy with Cadence Design Systems, which reported strong Q3 earnings.

<p>The UK's antitrust watchdog has <a href="https://www.gov.uk/cma-cases/synopsys-slash-ansys-merger-inquiry" target="_blank" rel="noreferrer noopener">launched an investigation</a> into <strong>Synopsys Inc</strong>'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) $34 billion acquisition of software developer <strong>Ansys Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANSS#NASDAQ">ANSS</a>).</p>
<p>On Friday, the Competition and Markets Authority (CMA) announced it had opened an initial phase one merger review due to potential competition concerns.</p>
<p>The CMA has recently intensified scrutiny in the tech sector, focusing on mergers involving AI, cloud services, and chip design, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-10-25/synopsys-34-billion-ansys-deal-gets-uk-antitrust-scrutiny?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">reports</a>.</p>
<p><strong><em>Also Read: </em></strong><em><a target="_blank" href="https://www.benzinga.com/news/24/09/41008834/ansys-taiwan-semiconductor-microsoft-team-up-to-supercharge-next-gen-chip-simulations" rel="noreferrer noopener">ANSYS, Taiwan Semiconductor, Microsoft Team Up To Supercharge Next-Gen Chip Simulations</a></em></p>
<p>Synopsys acquired Ansys to broaden its customer base and product offerings.</p>
<p>Under the deal, Ansys shareholders will <a href="https://www.benzinga.com/m-a/24/01/36646413/why-is-ansys-stock-trading-lower-tuesday" target="_blank" rel="noreferrer noopener">receive $197 in cash</a> and 0.345 shares of Synopsys stock for each Ansys share they own.</p>
<p>The CMA will determine by Dec. 20 whether the investigation will proceed to an in-depth review.</p>
<p>The CMA has <a target="_blank" href="https://www.benzinga.com/government/24/10/41528255/googles-2b-investment-in-anthropic-under-scrutiny-uk-opens-competition-inquiry" rel="noreferrer noopener">opened an investigation</a> into Google's $2 billion investment in AI startup Anthropic, assessing its potential impact on competition. This regulatory step follows CMA's recent approval of a similar Amazon-Anthropic partnership.</p>
<p>Microsoft, which invested $10 billion in OpenAI, recently gave up its observer seat on OpenAI's board amid rising global regulatory pressure on Big Tech's AI investments.</p>
<p><strong>Price Actions:</strong> ANSS stock was up 1.38% at $325.80, while shares of SNPS were up 1.5% at $502.48 at the time of publication Friday.</p>
<p><strong>Also Read:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/government/24/10/41522973/intel-triumphs-in-15-year-legal-battle-eu-court-rejects-record-antitrust-penalty" target="_blank" rel="noreferrer noopener">Intel Triumphs In 15-Year Legal Battle, EU Court Rejects Record Antitrust Penalty</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Government

Regulations

Tech

Media

UK Launches Antitrust Review Of Synopsys' $34 Billion Ansys Deal Over Growing Concerns

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>Baird raised <strong>ServiceNow, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) price target from $900 to $975. Baird analyst Rob Oliver maintained an Outperform rating. ServiceNow shares closed at $907.68 on Wednesday. <a href="https://www.benzinga.com/quote/NOW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc raised the price target for <strong>Rocket Lab USA, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) from $11 to $12. Keybanc analyst Michael Leshock maintained an Overweight rating. Rocket Lab shares closed at $10.91 on Wednesday. <a href="https://www.benzinga.com/quote/RKLB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler cut the price target for <strong>Synopsys, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) from $687 to $670. Piper Sandler analyst Clarke Jeffries maintained an Overweight rating. Synopsys shares closed at $493.41 on Wednesday. <a href="https://www.benzinga.com/quote/SNPS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. raised <strong>DBV Technologies S.A.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) price target from $5 to $7. HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating. DBV Technologies shares settled at $0.6801 on Wednesday. <a href="https://www.benzinga.com/quote/DBVT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham boosted <strong>Teledyne Technologies Incorporated</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) price target from $482 to $528. Needham analyst James Ricchiuti maintained a Buy rating. Teledyne Technologies shares closed at $470.09 on Wednesday. <a href="https://www.benzinga.com/quote/TDY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut <strong>NextEra Energy Partners, LP</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEP#NYSE">NEP</a>) price target from $25 to $22. JP Morgan analyst Mark Strouse upgraded the stock from Underweight to Neutral. NextEra Energy shares closed at $21.01 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See </a><a href="https://www.benzinga.com/quote/NEP/analyst-ratings">how </a><a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">other analysts view this stock</a>.</li>
<li>BMO Capital cut the price target for <strong>CoStar Group, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) from $78 to $75. BMO Capital analyst Jeffrey Silber maintained a Market Perform rating. CoStar shares settled at $72.82 on Wednesday. <a href="https://www.benzinga.com/quote/CSGP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised <strong>Amphenol Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) price target from $70 to $74. B of A Securities analyst Wamsi Mohan maintained a Neutral rating. Amphenol shares closed at $68.47 on Wednesday. <a href="https://www.benzinga.com/quote/APH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised the price target for <strong>Tesla, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) from $255 to $265. B of A Securities analyst John Murphy maintained a Buy rating. Tesla shares closed at $213.65 on Wednesday. <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co. boosted <strong>East West Bancorp, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) price target from $91 to $104. Stephens &amp; Co. analyst Andrew Terrell maintained an Overweight rating. East West Bancorp shares closed at $95.63 on Wednesday. <a href="https://www.benzinga.com/quote/EWBC/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
<p><strong>Read More:</strong></p>
<ul>
<li><strong> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41512422/top-3-tech-stocks-youll-regret-missing-in-q4">Top 3 Tech Stocks You&#8217;ll Regret Missing In Q4</a></strong></li>
</ul>


Pre-Market Outlook

CSGP

DBVT

EWBC

RKLB

TSLA

Tesla To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday

<p>Piper Sandler  analyst Clarke Jeffries   maintains Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Overweight and lowers the price target from $687 to $670.</p>


Piper Sandler Maintains Overweight on Synopsys, Lowers Price Target to $670

<p>Investors with significant funds have taken a bullish position in Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), a development that retail traders should be aware of.</p>
<p>This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. The exact nature of these investors remains a mystery, but such a major move in SNPS usually indicates foreknowledge of upcoming events.</p>
<p>Today, Benzinga's options scanner identified 8 options transactions for Synopsys. This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 62% being bullish and 25% bearish. Of all the options we discovered, 7 are puts, valued at $246,230, and there was a single call, worth $75,900.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $520.0 and $600.0 for Synopsys, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Synopsys's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Synopsys's whale activity within a strike price range from $520.0 to $600.0 in the last 30 days. </p>
<h3>Synopsys Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1729605666_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$23.5</td>
<td>$23.0</td>
<td>$23.0</td>
<td>$520.00</td>
<td>$75.9K</td>
<td style="text-align: right;">93</td>
<td style="text-align: right;">33</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$106.0</td>
<td>$104.2</td>
<td>$104.2</td>
<td>$600.00</td>
<td>$41.6K</td>
<td style="text-align: right;">704</td>
<td style="text-align: right;">20</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$104.1</td>
<td>$102.0</td>
<td>$102.0</td>
<td>$600.00</td>
<td>$40.8K</td>
<td style="text-align: right;">704</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$104.1</td>
<td>$101.1</td>
<td>$101.1</td>
<td>$600.00</td>
<td>$40.4K</td>
<td style="text-align: right;">704</td>
<td style="text-align: right;">4</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$104.1</td>
<td>$99.3</td>
<td>$99.3</td>
<td>$600.00</td>
<td>$39.7K</td>
<td style="text-align: right;">704</td>
<td style="text-align: right;">8</td>
</tr>
</tbody>
</table>
</p>
<h3>About Synopsys</h3>
<p>Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.</p>
<p>Following our analysis of the options activities associated with Synopsys, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Synopsys</h3>
<ul>
<li>With a trading volume of 35,433, the price of SNPS is down by -1.11%, reaching $500.0.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 36 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Synopsys</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $650.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $640.<br />
&#x2A; An analyst from Berenberg downgraded its action to Buy with a price target of $660.<br />
&#x2A; In a cautious move, an analyst from Mizuho downgraded its rating to Outperform, setting a price target of $650. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Synopsys options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Market Whales and Their Recent Bets on SNPS Options

<p>Ratings for Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $655.0, a high estimate of $687.00, and a low estimate of $635.00. This upward trend is apparent, with the current average reflecting a 1.15% increase from the previous average price target of $647.57.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1729598447_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Synopsys. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$640.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Outperform</td>
<td>$650.00</td>
<td>-</td>
</tr>
<tr>
<td>Nay Soe Naing</td>
<td>Berenberg</td>
<td>Announces</td>
<td>Buy</td>
<td>$660.00</td>
<td>-</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$635.00</td>
<td>$635.00</td>
</tr>
<tr>
<td>Harlan Sur</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$685.00</td>
<td>$655.00</td>
</tr>
<tr>
<td>Joe Vruwink</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$663.00</td>
<td>$661.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$640.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Clarke Jeffries</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$687.00</td>
<td>$687.00</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$635.00</td>
<td>$615.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Synopsys. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Synopsys compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Synopsys's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Synopsys's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SNPS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Synopsys analyst ratings.</strong></a></p>
<h2>All You Need to Know About Synopsys</h2>
<p>Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.</p>
<h3>Understanding the Numbers: Synopsys's Finances</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Revenue Growth:</strong> Synopsys's revenue growth over a period of 3 months has been noteworthy. As of 31 July, 2024, the company achieved a revenue growth rate of approximately <strong>12.65%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Synopsys's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>26.74%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Synopsys's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>5.49%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Synopsys's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>3.6%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Synopsys's debt-to-equity ratio is below the industry average at <strong>0.09</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings For Synopsys

<p>Needham  analyst Charles Shi   reiterates Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy and maintains $640 price target.</p>


Reiteration

Needham Reiterates Buy on Synopsys, Maintains $640 Price Target

<p>Mizuho  analyst Siti Panigrahi   initiates coverage on Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Outperform rating and announces Price Target of $650.</p>


Mizuho Initiates Coverage On Synopsys with Outperform Rating, Announces Price Target of $650

<p><strong>Synopsys's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NYSE">SNPS</a>) short percent of float has risen 7.43% since its last report. The company recently reported that it has <strong>2.88 million shares sold short</strong>, which is 1.88% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.83 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Synopsys Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1729526431_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Synopsys has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Synopsys's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Synopsys's peer group average for short interest as a percentage of float is 3.25%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

(SNPS) - Analyzing Synopsys's Short Interest

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Synopsys</strong>.</p>
<p>Looking at options history for Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) we detected 21 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 28% of the investors opened trades with bullish expectations and 33% with bearish.</p>
<p>From the overall spotted trades, 5 are puts, for a total amount of $423,980 and 16, calls, for a total amount of $811,190.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $420.0 and $610.0 for Synopsys, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Synopsys's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Synopsys's significant trades, within a strike price range of $420.0 to $610.0, over the past month.</p>
<h3>Synopsys Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1729284326_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$55.0</td>
<td>$50.8</td>
<td>$50.8</td>
<td>$420.00</td>
<td>$213.3K</td>
<td style="text-align: right;">80</td>
<td style="text-align: right;">42</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$63.3</td>
<td>$61.0</td>
<td>$61.0</td>
<td>$600.00</td>
<td>$91.5K</td>
<td style="text-align: right;">150</td>
<td style="text-align: right;">64</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$31.9</td>
<td>$31.4</td>
<td>$31.6</td>
<td>$510.00</td>
<td>$69.5K</td>
<td style="text-align: right;">103</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$31.9</td>
<td>$31.5</td>
<td>$31.5</td>
<td>$510.00</td>
<td>$63.0K</td>
<td style="text-align: right;">103</td>
<td style="text-align: right;">72</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$61.0</td>
<td>$60.0</td>
<td>$60.0</td>
<td>$600.00</td>
<td>$60.0K</td>
<td style="text-align: right;">150</td>
<td style="text-align: right;">116</td>
</tr>
</tbody>
</table>
</p>
<h3>About Synopsys</h3>
<p>Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.</p>
<p>Following our analysis of the options activities associated with Synopsys, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Synopsys Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 854,725, with SNPS's price up by 0.46%, positioned at $507.03.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 40 days.</li>
</ul>
<h3>What Analysts Are Saying About Synopsys</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $660.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from Berenberg downgraded its rating to Buy, setting a price target of $660. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Synopsys, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Behind the Scenes of Synopsys's Latest Options Trends

CDNS

INTZ

VERB

ZENA

Shares of software companies are trading lower. The sector may be falling amid sympathy for overall market weakness after ASML and UnitedHealth Group reported Q3 results.

<p>During the last three months, 7 analysts shared their evaluations of Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $657.86, a high estimate of $687.00, and a low estimate of $635.00. Observing a 1.39% increase, the current average has risen from the previous average price target of $648.83. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1729000846_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The standing of Synopsys among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nay Soe Naing</td>
<td>Berenberg</td>
<td>Announces</td>
<td>Buy</td>
<td>$660.00</td>
<td>-</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$635.00</td>
<td>$635.00</td>
</tr>
<tr>
<td>Harlan Sur</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$685.00</td>
<td>$655.00</td>
</tr>
<tr>
<td>Joe Vruwink</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$663.00</td>
<td>$661.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$640.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Clarke Jeffries</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$687.00</td>
<td>$687.00</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$635.00</td>
<td>$615.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Synopsys. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Synopsys compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Synopsys's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Synopsys's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SNPS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Synopsys analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Synopsys</h2>
<p>Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.</p>
<h3>Key Indicators: Synopsys's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Revenue Growth:</strong> Synopsys displayed positive results in 3 months. As of 31 July, 2024, the company achieved a solid revenue growth rate of approximately <strong>12.65%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Synopsys's net margin excels beyond industry benchmarks, reaching <strong>26.74%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Synopsys's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>5.49%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Synopsys's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>3.6%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Synopsys's debt-to-equity ratio is below the industry average at <strong>0.09</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Navigating 7 Analyst Ratings For Synopsys

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>BTIG analyst Gregory Lewis initiated coverage on <strong>DHT Holdings, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHT#NYSE">DHT</a>) with a Buy rating and announced a price target of $16. DHT shares fell 3.2% to close at $11.34 on Monday. <a href="https://www.benzinga.com/quote/DHT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Berenberg analyst Nay Soe Naing initiated coverage on <strong>Synopsys, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy rating and announced a price target of $660. Synopsys shares gained 1% to close at $545.46 on Monday. <a href="https://www.benzinga.com/quote/SNPS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Cantor Fitzgerald analyst Ross Osborn initiated coverage on <strong>LeMaitre Vascular</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMAT#NASDAQ">LMAT</a>) with a Neutral rating and announced a price target of $96. LeMaitre Vascular shares gained 1.7% to close at $92.14 on Monday. <a href="https://www.benzinga.com/quote/LMAT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Benchmark analyst Michael Albanese initiated coverage on <strong>MarineMax, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) with a Buy rating and announced a price target of $40. MarineMax shares gained 5.3% to close at $33.13 on Monday. <a href="https://www.benzinga.com/quote/HZO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Ryan Levine initiated coverage on <strong>Constellation Energy Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) with a Neutral rating and announced a price target of $284. Constellation Energy shares gained 2.1% to close at $271.74 on Monday. <a href="https://www.benzinga.com/quote/CEG/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
<p>Considering buying SNPS stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/15093223/image-116-1024x500.png" alt="" class="wp-image-596155" style="width:618px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/15093223/image-116-1024x500.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/15093223/image-116-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/15093223/image-116-768x375.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/15093223/image-116.png 1357w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read More:<a href="https://www.benzinga.com/markets/24/10/41327296/jim-cramer-is-worried-about-this-plane-maker-says-palo-alto-is-a-good-one"> </a></strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/24/10/41327296/jim-cramer-is-worried-about-this-plane-maker-says-palo-alto-is-a-good-one">Jim Cramer Is Worried About This Plane Maker, Says Palo Alto Is A &#8216;Good&#8217; One</a></strong></li>
</ul>


LMAT

This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

<p>Berenberg  analyst Nay Soe Naing   initiates coverage on Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy rating and announces Price Target of $660.</p>


Berenberg Initiates Coverage On Synopsys with Buy Rating, Announces Price Target of $660

Digi edges higher despite expecting no revenue growth in Q1 FY2025

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Synopsys</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/snps-stock-quote/"><strong>SNPS</strong></a></span>) just reported results for the third quarter of 2024.</p><ul><li>Synopsys reported earnings per share of $3.43. This was above the analyst estimate for EPS of $3.28.</li><li>The company reported revenue of $1.53 billion.</li><li>This was 0.39% better than the analyst estimate for revenue of $1.52 billion.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div>	
	<p>The post <a href="https://investorplace.com/earning-results/2024/08/snps-stock-earnings-synopsys-for-q3-of-2024/">SNPS Stock Earnings: Synopsys Beats EPS, Beats Revenue for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

SNPS Stock Earnings: Synopsys Beats EPS, Beats Revenue for Q3 2024

Fidelity Magellan Fund Q3 2024 Review

Keysight Technologies: Gradual Green Shoots (Rating Downgrade)

Intuit: Maintaining Course As Earnings Approach

High Alpha stocks that are rated 'overweight' – MS

Franklin DynaTech SMA Q3 2024 Commentary

Franklin Growth Fund Q3 2024 Commentary

Synopsys (SNPS) has received a new Hold rating, initiated by Wells Fargo analyst, Joseph Quatrochi. Joseph Quatrochi has given his Hold rating due ...

Hold Rating on Synopsys Amid Uncertainty of Ansys Acquisition and AI Monetization Delays

Wells Fargo initiated coverage of Synopsys (SNPS) with an Equal Weight rating and $570 price target The firm thinks the shares could remain relativ...

Synopsys initiated with an Equal Weight at Wells Fargo

AAPL

ABBV

AMZN

ANET

ASML

AVGO

AXON

BBWI

COST

CTVA

DELL

DGII

FANG

FSLR

GOOG

GOOGL

INFN

INTC

KEYS

LPLA

LRCX

LTRX

MPWR

MSCI

MSFT

NFLX

NONOF

NTGR

NTNX

NVDA

PYPL

REGN

SAPGF

SILC

SPOT

SRPT

TEAM

TMUS

TRGP

Earnings

Press Releases

Synopsys Posts Financial Results for Third Quarter Fiscal Year 2024

Synopsys Powers World's Fastest UCIe-Based Multi-Die Designs with New IP Operating at 40 Gbps

Ethernet Innovation Drives Ethernet Alliance's ECOC 2024 Demo

Synopsys Advances Imaging System Development with Industry's First Complete Virtual Prototyping Platform

Keysight Advances Software-Centric Solutions Strategy with Planned Acquisition of Synopsys' Optical Solutions Group

Synopsys Enters Definitive Agreement with Keysight Technologies For Sale of Optical Solutions Group

Synopsys and TSMC Pave the Path for Trillion-Transistor AI and Multi-Die Chip Design

Clearlake and Francisco Partners Complete Acquisition of Black Duck Software, Formerly Known as Synopsys Software Integrity Group

Synopsys Announces Earnings Release Date For Fourth Quarter and Fiscal Year 2024

JNPR

Adobe

Comments

Synopsys

空売り

Synopsys (NASDAQ:SNPS) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル